Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dimopoulos

Showing results (181-190 of 288) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervixC A Papadimitriou, K Sarris, L A Moulopoulos, et al.
Leukemia|July 10, 2009
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myelomaM Roussou, A Tasidou, M A Dimopoulos, et al.
Seminars in Oncology|August 1, 1997
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimenV Georgoulias, C Kourousis, S Kakolyris, et al.
Leukemia & Lymphoma|June 1, 1997
Primary parotid lymphoma: the effect of International Prognostic Index on outcomeA H Sarris, V Papadimitrakopoulou, M A Dimopoulos, et al.
European Journal of Gynaecological Oncology|May 8, 2007
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experienceC A Papadimitriou, M P Zorzou, S Markaki, et al.
Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.
European Journal of Haematology|February 13, 2001
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study GroupK Zervas, A Pouli, B Gregoraki, et al.
Cancer Chemotherapy and Pharmacology|June 17, 2005
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerE Briasoulis, E Samantas, H Kalofonos, et al.
European Journal of Haematology|June 19, 2002
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOPT Economopoulos, M A Dimopoulos, S Mellou, et al.
Pageof 29

Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervixC A Papadimitriou, K Sarris, L A Moulopoulos, et al.
Leukemia|July 10, 2009
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myelomaM Roussou, A Tasidou, M A Dimopoulos, et al.
Seminars in Oncology|August 1, 1997
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimenV Georgoulias, C Kourousis, S Kakolyris, et al.
Leukemia & Lymphoma|June 1, 1997
Primary parotid lymphoma: the effect of International Prognostic Index on outcomeA H Sarris, V Papadimitrakopoulou, M A Dimopoulos, et al.
European Journal of Gynaecological Oncology|May 8, 2007
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experienceC A Papadimitriou, M P Zorzou, S Markaki, et al.
Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.
European Journal of Haematology|February 13, 2001
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study GroupK Zervas, A Pouli, B Gregoraki, et al.
Cancer Chemotherapy and Pharmacology|June 17, 2005
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerE Briasoulis, E Samantas, H Kalofonos, et al.
European Journal of Haematology|June 19, 2002
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOPT Economopoulos, M A Dimopoulos, S Mellou, et al.
Pageof 29